170 related articles for article (PubMed ID: 21205463)
21. Effects of zoledronate on markers of bone metabolism and subchondral bone mineral density in dogs with experimentally induced cruciate-deficient osteoarthritis.
Agnello KA; Trumble TN; Chambers JN; Seewald W; Budsberg SC
Am J Vet Res; 2005 Sep; 66(9):1487-95. PubMed ID: 16261820
[TBL] [Abstract][Full Text] [Related]
22. The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.
Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A
Biomaterials; 2012 Jan; 33(2):722-30. PubMed ID: 22014461
[TBL] [Abstract][Full Text] [Related]
23. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production.
Chang JK; Hsu YL; Teng IC; Kuo PL
Eur J Pharmacol; 2006 Dec; 551(1-3):1-9. PubMed ID: 17026990
[TBL] [Abstract][Full Text] [Related]
24. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
von Knoch F; Jaquiery C; Kowalsky M; Schaeren S; Alabre C; Martin I; Rubash HE; Shanbhag AS
Biomaterials; 2005 Dec; 26(34):6941-9. PubMed ID: 16009417
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells.
Ribeiro V; Garcia M; Oliveira R; Gomes PS; Colaço B; Fernandes MH
J Cell Mol Med; 2014 Jan; 18(1):27-37. PubMed ID: 24373581
[TBL] [Abstract][Full Text] [Related]
26. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
[TBL] [Abstract][Full Text] [Related]
27. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.
Cui P; Liu H; Sun J; Amizuka N; Sun Q; Li M
Histol Histopathol; 2018 Jan; 33(1):89-99. PubMed ID: 28345127
[TBL] [Abstract][Full Text] [Related]
28. The effect of bisphosphonates and titanium particles on osteoblasts: an in vitro study.
Peter B; Zambelli PY; Guicheux J; Pioletti DP
J Bone Joint Surg Br; 2005 Aug; 87(8):1157-63. PubMed ID: 16049257
[TBL] [Abstract][Full Text] [Related]
29. Osteoblast proliferation and maturation by bisphosphonates.
Im GI; Qureshi SA; Kenney J; Rubash HE; Shanbhag AS
Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901
[TBL] [Abstract][Full Text] [Related]
30. Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells.
Iguchi T; Miyakawa Y; Saito K; Nakabayashi C; Nakanishi M; Saya H; Ikeda Y; Kizaki M
Int J Oncol; 2007 Aug; 31(2):285-91. PubMed ID: 17611684
[TBL] [Abstract][Full Text] [Related]
31. Low zoledronate concentrations stimulate human keratinocyte proliferation.
Migliario M; Rizzi M; Rocchetti V; Pittarella P; Renò F
Pharmacology; 2013; 91(3-4):201-6. PubMed ID: 23428615
[TBL] [Abstract][Full Text] [Related]
32. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects.
Corrado A; Neve A; Macchiarola A; Gaudio A; Marucci A; Cantatore FP
J Rheumatol; 2013 May; 40(5):684-94. PubMed ID: 23457386
[TBL] [Abstract][Full Text] [Related]
33. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
34. No reduction in circulating preosteoclasts 18 months after treatment with zoledronate: analysis from a randomized placebo controlled trial.
Dalbeth N; Pool B; Stewart A; Horne A; House ME; Cornish J; Reid IR
Calcif Tissue Int; 2013 Jan; 92(1):1-5. PubMed ID: 23052228
[TBL] [Abstract][Full Text] [Related]
35. Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model.
Komatsu K; Shimada A; Shibata T; Wada S; Ideno H; Nakashima K; Amizuka N; Noda M; Nifuji A
J Endocrinol; 2013 Nov; 219(2):145-58. PubMed ID: 24096963
[TBL] [Abstract][Full Text] [Related]
36. Zoledronic acid inhibits human osteoblast activities.
Basso FG; Silveira Turrioni AP; Hebling J; de Souza Costa CA
Gerontology; 2013; 59(6):534-41. PubMed ID: 23867757
[TBL] [Abstract][Full Text] [Related]
37. Actions of calcipotriol (MC 903), a novel vitamin D3 analog, on human bone-derived cells: comparison with 1,25-dihydroxyvitamin D3.
Evans DB; Thavarajah M; Binderup L; Kanis JA
J Bone Miner Res; 1991 Dec; 6(12):1307-15. PubMed ID: 1792941
[TBL] [Abstract][Full Text] [Related]
38. Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.
Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
Clin Oral Investig; 2016 Nov; 20(8):2023-2035. PubMed ID: 26795621
[TBL] [Abstract][Full Text] [Related]
39. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic and inflammatory effects of alendronate and zolendronate on human osteoblasts, gingival fibroblasts and osteosarcoma cells.
Açil Y; Arndt ML; Gülses A; Wieker H; Naujokat H; Ayna M; Wiltfang J
J Craniomaxillofac Surg; 2018 Apr; 46(4):538-546. PubMed ID: 29454604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
